Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Qiagen n.v. symbols : MRTX save search
QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer
Published: 2022-12-13 (Crawled : 11:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 2.13%
H: 0.3%
C: -2.2%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 2.13%
H: 0.3%
C: -2.2%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 1.16%
H: 1.41%
C: 0.19%
fda lung diagnostic approval cancer
QIAGEN Partners With Mirati Therapeutics Inc. to Develop KRASG12C Companion Diagnostic for Non-Small Cell Lung Cancer (NSCLC)
Published: 2021-05-25 (Crawled : 01:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.54%
H: 0.33%
C: 0.23%
QGEN | $39.47 0.61% 0.0% 950K
|
Health Technology
|
| O: 0.54%
H: 0.33%
C: 0.23%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 0.31%
H: 1.16%
C: -1.15%
lung cancer cancer diagnostic
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 900K
|
OST | $0.499 21.38% 45.26% 1.9M
|
ZCMD | $2.44 78.1% 43.85% 330K
|
Commercial Services
XPON | $3.1 60.62% 37.74% 16M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.